The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund, providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage.
The BTB program is operated by MTPConnect in partnership with BioCurate, UniQuest, the Medical Device Partnering Program and the Bridge and BridgeTech programs.
BioCurate Director of Partnerships Dr Eric Hayes will be in attendance. Please join us and our partners at the University of Sydney to find out more about the BTB Program.